Fmr LLC maintained its position in Aradigm Corporation (NASDAQ:ARDM) during the first quarter, Holdings Channel reports. The firm owned 168,740 shares of the company’s stock at the end of the first quarter. Fmr LLC’s holdings in Aradigm Corporation were worth $263,000 at the end of the most recent reporting period.
Shares of Aradigm Corporation (NASDAQ ARDM) opened at 1.37 on Thursday. Aradigm Corporation has a 12-month low of $0.78 and a 12-month high of $7.19. The stock has a 50 day moving average of $1.35 and a 200 day moving average of $1.52. The company’s market cap is $20.28 million.
Aradigm Corporation (NASDAQ:ARDM) last posted its earnings results on Monday, May 15th. The company reported ($0.25) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.43) by $0.18. The company had revenue of $1.69 million for the quarter. Aradigm Corporation had a negative net margin of 1,515.94% and a negative return on equity of 665.03%. Equities research analysts predict that Aradigm Corporation will post ($1.10) earnings per share for the current fiscal year.
Separately, Zacks Investment Research upgraded shares of Aradigm Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, July 11th.
About Aradigm Corporation
Aradigm Corporation is a pharmaceutical company focused on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. The Company’s lead product candidate is Pulmaquin inhaled ciprofloxacin, which is in Phase III clinical trials. It offers AERx pulmonary drug delivery platform and other technologies.
Want to see what other hedge funds are holding ARDM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aradigm Corporation (NASDAQ:ARDM).
Receive News & Ratings for Aradigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aradigm Corporation and related companies with MarketBeat.com's FREE daily email newsletter.